Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 4057024)

Published in Crit Care on April 25, 2014

Authors

François Lauzier, John Muscedere, Eric Deland, Demetrios Jim Kutsogiannis, Michael Jacka, Diane Heels-Ansdell, Mark Crowther, Rodrigo Cartin-Ceba, Michael J Cox, Nicole Zytaruk, Denise Foster, Tasnim Sinuff, France Clarke, Patrica Thompson, Steven Hanna, Deborah Cook, Co-operative Network of Critical Care Knowledge Translation for Thromboprophylaxis (CONECCKT-T) Investigators, Canadian Critical Care Trials Group

Articles cited by this

APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17

Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol (2006) 8.02

Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation (2005) 5.38

Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.02

Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med (2011) 4.59

Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 4.30

Reviewing audit: barriers and facilitating factors for effective clinical audit. Qual Health Care (2000) 2.52

Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med (2013) 2.52

Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest (2007) 2.32

Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med (2005) 1.87

Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill? Crit Care Med (2003) 1.87

Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med (2013) 1.77

Implementation of clinical practice guidelines for ventilator-associated pneumonia: a multicenter prospective study. Crit Care Med (2013) 1.68

Omission of early thromboprophylaxis and mortality in critically ill patients: a multicenter registry study. Chest (2011) 1.66

Guideline-discordant care in acute myocardial infarction: predictors and outcomes. Med J Aust (2002) 1.54

Minimizing errors of omission: behavioural reenforcement of heparin to avert venous emboli: the BEHAVE study. Crit Care Med (2006) 1.52

Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet (2002) 1.32

Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study. Arch Intern Med (2008) 1.28

Antifactor Xa activity in intensive care patients receiving thromboembolic prophylaxis with standard doses of enoxaparin. Thromb Res (2002) 1.27

Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study. Crit Care (2006) 1.22

Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial. Crit Care (2010) 1.17

Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis. Thromb Haemost (2009) 1.16

Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients. J Crit Care (2000) 1.14

Bleeding during critical illness: a prospective cohort study using a new measurement tool. Clin Invest Med (2007) 1.10

Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey. Crit Care (2001) 1.05

Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function: a comparative pharmacokinetic study. Thromb Haemost (2007) 1.03

Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study. J Crit Care (2003) 1.00

Mechanical thromboprophylaxis in critically ill patients: a systematic review and meta-analysis. Am J Crit Care (2006) 1.00

Coagulation Day 2010: an Austrian survey on the routine of thromboprophylaxis in intensive care. Intensive Care Med (2012) 0.96

Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors. Crit Care (2008) 0.96

Testing for heparin-induced thrombocytopenia antibodies. Transfus Med Rev (2006) 0.92

Thromboprophylaxis for hospitalized medical patients: a multicenter qualitative study. J Hosp Med (2009) 0.91

A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial. Crit Care (2013) 0.88

Venous thromboembolism in critical illness in a community intensive care unit. J Crit Care (2007) 0.87

Prevention of venous thromboembolism in critically ill surgery patients: a cross-sectional study. J Crit Care (2001) 0.86

Variability in the use of thromboprophylaxis and outcomes in critically ill medical patients. Am J Med (2005) 0.80

Prevention of venous thromboembolism after injury. Evid Rep Technol Assess (Summ) (2000) 0.79

Articles by these authors

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68

Intensive versus conventional glucose control in critically ill patients. N Engl J Med (2009) 26.30

Evolutionary and biomedical insights from the rhesus macaque genome. Science (2007) 16.21

One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med (2003) 11.77

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 10.75

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39

A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med (2003) 10.13

Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med (2011) 9.96

A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med (2013) 8.94

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94

Transfusion strategies for patients in pediatric intensive care units. N Engl J Med (2007) 7.21

A guide for the design and conduct of self-administered surveys of clinicians. CMAJ (2008) 6.72

Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. JAMA (2012) 6.69

High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med (2013) 6.56

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood (2011) 6.50

Hypoglycemia and risk of death in critically ill patients. N Engl J Med (2012) 6.17

Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10

Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA (2010) 5.90

Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery--a prospective sequential analysis*. Crit Care Med (2013) 5.88

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.88

Systematic overview of warfarin and its drug and food interactions. Arch Intern Med (2005) 5.86

A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med (2006) 5.74

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.57

A Trial of Wound Irrigation in the Initial Management of Open Fracture Wounds. N Engl J Med (2015) 5.28

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 4.82

Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA (2010) 4.64

Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med (2011) 4.59

Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58

Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 4.41

Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol (2014) 4.39

Toothbrushing for critically ill mechanically ventilated patients: a systematic review and meta-analysis of randomized trials evaluating ventilator-associated pneumonia. Crit Care Med (2013) 4.29

Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96

Failure to engage hospitalized elderly patients and their families in advance care planning. JAMA Intern Med (2013) 3.77

Clinical consequences of red cell storage in the critically ill. Transfusion (2006) 3.57

Publication bias in editorial decision making. JAMA (2002) 3.52

The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med (2010) 3.47

A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant (2010) 3.45

Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med (2013) 3.40

Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 3.14

Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med (2010) 3.10

Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation (2009) 3.10

Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ (2007) 3.06

Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med (2006) 3.06

Rationing critical care beds: a systematic review. Crit Care Med (2004) 2.86

The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med (2015) 2.85

Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.83

Fluids after cardiac surgery: a pilot study of the use of colloids versus crystalloids. Crit Care Med (2010) 2.82

The Very Elderly Admitted to ICU: A Quality Finish? Crit Care Med (2015) 2.77

Pulmonary arteriovenous malformations. Chest (2013) 2.77

Payments for care at private for-profit and private not-for-profit hospitals: a systematic review and meta-analysis. CMAJ (2004) 2.76

Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med (2006) 2.76

Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost (2011) 2.75

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One (2012) 2.75

One-Year Outcomes in Caregivers of Critically Ill Patients. N Engl J Med (2016) 2.73

Facilitating clinician adherence to guidelines in the intensive care unit: A multicenter, qualitative study. Crit Care Med (2007) 2.72

Acute rehabilitation practices in critically ill children: a multicenter study. Pediatr Crit Care Med (2014) 2.71

Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study). Intensive Care Med (2014) 2.70

Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ (2012) 2.69

Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid. J Clin Epidemiol (2011) 2.69

Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med (2008) 2.68

A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med (2013) 2.68

Clinical practice guidelines for the use of noninvasive positive-pressure ventilation and noninvasive continuous positive airway pressure in the acute care setting. CMAJ (2011) 2.67

Longitudinal changes in procalcitonin in a heterogeneous group of critically ill patients. Crit Care Med (2012) 2.65

Clinician predictions of intensive care unit mortality. Crit Care Med (2004) 2.65

Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med (2003) 2.59

An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol (2004) 2.58

Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol (2009) 2.56

Age of transfused blood in critically ill adults. N Engl J Med (2015) 2.52

Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med (2013) 2.52

Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials. Arch Intern Med (2007) 2.50

Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.50

Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev (2002) 2.49

Antiphospholipid syndrome. Lancet (2010) 2.47

Evidence based medicine has come a long way. BMJ (2004) 2.42

A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS (2010) 2.42

Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med (2006) 2.39

Nonleg venous thrombosis in critically ill adults: a nested prospective cohort study. JAMA Intern Med (2014) 2.36

Probiotics in the critically ill: a systematic review of the randomized trial evidence. Crit Care Med (2012) 2.35

Red blood cell transfusion thresholds in pediatric patients with sepsis. Pediatr Crit Care Med (2011) 2.35

Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 2.28

Predicting deep venous thrombosis in pregnancy: out in "LEFt" field? Ann Intern Med (2009) 2.26

Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med (2015) 2.25

Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest (2013) 2.24